vorinostat has been researched along with Movement Disorders in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hockly, E | 1 |
| Richon, VM | 1 |
| Woodman, B | 1 |
| Smith, DL | 1 |
| Zhou, X | 1 |
| Rosa, E | 1 |
| Sathasivam, K | 1 |
| Ghazi-Noori, S | 1 |
| Mahal, A | 1 |
| Lowden, PA | 1 |
| Steffan, JS | 1 |
| Marsh, JL | 1 |
| Thompson, LM | 1 |
| Lewis, CM | 1 |
| Marks, PA | 1 |
| Bates, GP | 1 |
1 other study available for vorinostat and Movement Disorders
| Article | Year |
|---|---|
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease.
Topics: Acetylation; Animals; Base Sequence; Blood-Brain Barrier; Brain; Disease Models, Animal; DNA Primers | 2003 |